Skip to main content
. 2022 Jun 2;13:883483. doi: 10.3389/fphar.2022.883483

TABLE 5.

Identification of suspected drugs, frequency, and management of ADRs among DR-TB patients (n = 271).

Adverse drug reaction Suspected drugs ADR frequency (%) Action taken Modified RR/MDR-TB regiment Type of Action taken
Dose reduction Temporary withdrawal Permanent withdrawal
Gastrointestinal Disturbances 181 (66.7)
 Gastrointestinal upset H, PAS, Cs, Eto 146 (53.8) Counselled and reassured. Patients were prescribed PPI along with prokinetics drugs. Medication was modified for one patient and was replaced with Lzd PAS (1) PAS (1)
 Nausea and Vomiting PAS 29 (10.7) Counselled and reassured. All patients were prescribed domperidone along with prokinetics drugs. PAS dose was reduced in one patient PAS (1)
 Diarrhea PAS, H 4 (1.47) Patients were prescribed diosmectite powder
 Hiccups 1 (0.36) The patient was prescribed Baclofen along with PPI
 Oral Ulcer 1 (0.36) The patient was prescribed Lignocaine gel and advised for use of mouthwash
Nervous System Disorders Cs 161 (59.4)
 Depression Cs 75 (27.6) Counselled and prescribed SSRI antidepressants. The dose of Vit B6 was also increased. The offending agent was withheld temporarily in one patient and dose was reduced in another patient Cs (2) Cs (1) Cs (1)
 Sleep disturbances Cs 48 (17.7) All patients were counselled and prescribed Benzodiazepines None
 Psychosis Cs 27 (10) All the patients were prescribed antipsychotic medication after referral to the psychiatry ward. 27 patients were prescribed risperidone. The offending drug was temporarily and permanently stopped in two and one patient, respectively, and dose was reduced in one patient Cs (5) Cs (2) Cs (2) Cs (1)
 Aggression Cs 5 (1.84) Counselled and referred to the psychiatry ward. All patients were prescribed Fluphenazine HCl and nortriptyline None
 Visual disturbances 4 (1.47) Patients were counselled and were referred to an ophthalmologist. Vit B6 dose was increased in all patients None
 Memory loss Cs 2 (0.7) The patients were prescribed a higher dose of Vit B6 None
Electrolyte disturbances Am 151 (55.7) Patients were monitored and two patients were advised for potassium-rich food and a potassium supplement was added to two patients’ treatment regimen due to Hypokalemia None
Arthralgia/Hyperuricemia Z, Cs, H 137 (49.1) Patients were prescribed NSAIDs for symptomatic relief. One patient was prescribed Allopurinol and dose of Z was reduced in another patient Z (1) Z (1)
Ototoxicity Am, S 65 (24) Counselled. Am was replaced to Cm in 33 patients and dose was reduced in nine patients while use was withheld temporarily and permanently in one and three patients, respectively. Nine patients were kept without management as they had completed their injectable treatment and this ADR was subsided Am (45) S (1) Am (9) Am (1) Am (3)
Pruritis/Rash/Acne Am 35 (12.9) Counselling was provided to patients. Antihistamine and hydrocortisone therapy was prescribed along with the use of r Skin emollients. Fusidic acid was prescribed for one patient. Two patients were prescribed anti-acne therapy None
Dyspnoea 34 (12.5) All patients were counselled and prescribed a bronchodilator None
Body Pain and Headache 27 (10) All patients were counselled and prescribed NSAIDs None
Tinnitus Am, Cm, Eto 24 (8.8) All patients were counselled and prescribed Betahistine. The Injection was stopped temporarily in one patient and advised on an alternate day in another patient Cm (2) Cm (1) Cm (1)
Peripheral neuropathy Cs 14 (5.2) All patients were counselled and prescribed duloxetine and vit B6 dose was increased None
Anorexia 7 (2.58) All patients were prescribed appetizers and multivitamins None
Hypothyroidism PAS 5 (1.84) All were counselled and prescribed thyroxine. Use of the offending agent was stopped in one patient and dose was reduced in another patient PAS (2) PAS (1) PAS (1)
Dizziness Z, Cs 4 (1.47) Patients were counselled. The dose of Vit B6 was increased in all patients. Z was advised to be taken on an alternate day in one patient. one patient was prescribed Prochlorperazine, and another patient was prescribed Betahistine Z (1) Z (1)
Hemoptysis 3 (1.1) Patients were counselled. All three patients were prescribed Tranexamic acid None
Anemia PAS 2 (0.7) Patients were counselled. One patient was prescribed for iron supplement and one patient was advised for blood transfusion along with the temporary withdrawal of the offending agents PAS (2) PAS (2)
Nephrotoxicity Cm 2 (0.7) Patients were counselled and prescribed prednisolone along with the removal of the offending agent permanently in one patient and replaced with Lzd in another patient Cm (2) Cm (2)
Palpitations 2 (0.7) Counselling was provided to the patients. Beta-blockers were prescribed None
Gynecomastia 2 (0.7) NSAIDs were added to patients’ treatment along with counselling None
Menstrual irregularities Eto 1 (0.36) The patient was counselled and referred to a gynecologist None
Photosensitivity Eto 1 (0.36) The patient was prescribed a higher dose of Vit B6 None
Swelling 1 (0.36) The patient was counselled and prescribed a diuretic None

H, isoniazid; Cs, cycloserine; Eto, ethionamide; PAS, para-amino salicylic acid; Z, pyrazinamide; Am, amikacin; Cm, capreomycin; S, streptomycin; NSAID, non-steroidal anti-inflammatory drugs; Lzd, linezolid; vit, vitamin.